Success Metrics

Clinical Success Rate

80.0%

Based on 4 completed trials

Completion Rate

80%(4/5)

Active Trials

0(0%)

Results Posted

50%(2 trials)

Terminated

1(14%)

Phase Distribution

Ph phase_1

86%

Ph phase_4

14%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution7 total trials

Phase 1Safety & dosage

6(85.7%)

Phase 4Post-market surveillance

1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(2)

Other(1)

Detailed Status

Completed4

unknown1

Withdrawn1

Terminated1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

80.0%

Most Advanced

Phase 4

Trials by Phase

Phase 16 (85.7%)

Phase 41 (14.3%)

Trials by Status

unknown114%

withdrawn114%

terminated114%

completed457%

Recent Activity

0 active trials

Showing 5 of 7

withdrawnphase_4

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

NCT01075126

completedphase_1

Clinical Trials (7)

Showing 7 of 7 trials

NCT01075126Phase 4

Safety Study of Depakote Versus Lithium in African Americans With Bipolar Disorder

Withdrawn

NCT00974012Phase 1

Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions

Completed

NCT00974441Phase 1

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

Completed

NCT00834639Phase 1

Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions

Completed

NCT00834990Phase 1

Divalproex Sodium Delayed-Release Tablets Under Non-Fasting Conditions

Completed

NCT00195156Phase 1

Treatment With ATRA-IV and Depakote in Patients With Advanced Solid Tumor Malignancies

Terminated

NCT00197834Phase 1

Study of Depakote for Behavioral and Psychological Symptoms in Dementia

Unknown

All 7 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 7